{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:45:29Z","timestamp":1793756729786,"version":"4.6.1"},"reference-count":154,"publisher":"Elsevier","isbn-type":[{"value":"9780443134555","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.vh.2023.03.001","type":"book-chapter","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T22:07:13Z","timestamp":1680214033000},"page":"249-284","source":"Crossref","is-referenced-by-count":14,"title":["Hepcidin and its multiple partners: Complex regulation of iron metabolism in health and disease"],"prefix":"10.1016","author":[{"given":"Yelena Z.","family":"Ginzburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/bs.vh.2023.03.001_bb0010","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1182\/blood-2009-04-215848","article-title":"Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease","volume":"115","author":"Akada","year":"2010","journal-title":"Blood"},{"key":"10.1016\/bs.vh.2023.03.001_bb0015","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.335","article-title":"BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism","volume":"41","author":"Andriopoulos","year":"2009","journal-title":"Nature Genetics"},{"issue":"1","key":"10.1016\/bs.vh.2023.03.001_bb784","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.chom.2014.12.001","article-title":"Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus","volume":"17","author":"Arezes","year":"2015","journal-title":"Cell Host & Microbe"},{"issue":"14","key":"10.1016\/bs.vh.2023.03.001_bb0025","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2018-06-857995","article-title":"Erythroferrone inhibits the induction of hepcidin by BMP6","volume":"132","author":"Arezes","year":"2018","journal-title":"Blood"},{"issue":"8","key":"10.1016\/bs.vh.2023.03.001_bb0030","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1182\/blood-2017-05-786590","article-title":"Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin","volume":"131","author":"Aschemeyer","year":"2018","journal-title":"Blood"},{"issue":"13","key":"10.1016\/bs.vh.2023.03.001_bb0035","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2016-09-740092","article-title":"Momelotinib inhibits ACVR1\/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents","volume":"129","author":"Asshoff","year":"2017","journal-title":"Blood"},{"key":"10.1016\/bs.vh.2023.03.001_bb0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng1777","article-title":"Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression","volume":"38","author":"Babitt","year":"2006","journal-title":"Nature Genetics"},{"issue":"7","key":"10.1016\/bs.vh.2023.03.001_bb0045","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1172\/JCI31342","article-title":"Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance","volume":"117","author":"Babitt","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/bs.vh.2023.03.001_bb782","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1542\/peds.2010-2576","article-title":"Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age)","volume":"126","author":"Baker","year":"2010","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/bs.vh.2023.03.001_bb0050","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/S2352-3026(20)30373-2","article-title":"Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): A multicentre, randomised phase 2 trial","volume":"8","author":"Barbui","year":"2021","journal-title":"The Lancet Haematology"},{"issue":"9464","key":"10.1016\/bs.vh.2023.03.001_bb0055","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"issue":"6765","key":"10.1016\/bs.vh.2023.03.001_bb0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/47417","article-title":"Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor","volume":"403","author":"Bennett","year":"2000","journal-title":"Nature"},{"issue":"10","key":"10.1016\/bs.vh.2023.03.001_bb0065","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/bph.13433","article-title":"Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects","volume":"173","author":"Boyce","year":"2016","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"10.1016\/bs.vh.2023.03.001_bb0070","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jhep.2007.12.021","article-title":"2-Oxoglutarate-dependent oxygenases control hepcidin gene expression","volume":"48","author":"Braliou","year":"2008","journal-title":"Journal of Hepatology"},{"issue":"9358","key":"10.1016\/bs.vh.2023.03.001_bb0075","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(03)12602-5","article-title":"Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis","volume":"361","author":"Bridle","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/bs.vh.2023.03.001_bb0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbagen.2011.07.014","article-title":"Non-transferrin bound iron: A key role in iron overload and iron toxicity","volume":"1820","author":"Brissot","year":"2012","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.vh.2023.03.001_bb0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/blood-2009-10-251496","article-title":"Iron control of erythroid development by a novel aconitase-associated regulatory pathway","volume":"116","author":"Bullock","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/bs.vh.2023.03.001_bb0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.beha.2004.10.003","article-title":"LPI-labile plasma iron in iron overload","volume":"18","author":"Cabantchik","year":"2005","journal-title":"Best Practice & Research. Clinical Haematology"},{"issue":"2","key":"10.1016\/bs.vh.2023.03.001_bb0095","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3324\/haematol.2019.232124","article-title":"Iron metabolism and iron disorders revisited in the hepcidin era","volume":"105","author":"Camaschella","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/bs.vh.2023.03.001_bb0100","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3324\/haematol.2012.069807","article-title":"The murine growth differentiation factor 15 is not essential for systemic iron homeostasis in phlebotomized mice","volume":"98","author":"Casanovas","year":"2013","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/bs.vh.2023.03.001_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251995","article-title":"Tmprss6-ASO as a tool for the treatment of Polycythemia Vera mice","volume":"16","author":"Casu","year":"2021","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/bs.vh.2023.03.001_bb0110","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1182\/blood-2017-11-737411","article-title":"Hepcidin agonists as therapeutic tools","volume":"131","author":"Casu","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/bs.vh.2023.03.001_bb0115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2015-10-676742","article-title":"Minihepcidin peptides as disease modifiers in mice affected by \u03b2-thalassemia and polycythemia vera","volume":"128","author":"Casu","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/bs.vh.2023.03.001_bb0120","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/IAI.74.5.3065-3067.2006","article-title":"The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica","volume":"74","author":"Chlosta","year":"2006","journal-title":"Infection and Immunity"},{"key":"10.1016\/bs.vh.2023.03.001_bb0125","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1053\/j.gastro.2010.07.044","article-title":"BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice","volume":"139","author":"Corradini","year":"2010","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/bs.vh.2023.03.001_bb0130","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1073\/pnas.80.8.2258","article-title":"pH and the recycling of transferrin during receptor-mediated endocytosis","volume":"80","author":"Dautry-Varsat","year":"1983","journal-title":"PNAS"},{"key":"10.1016\/bs.vh.2023.03.001_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cmet.2005.01.003","article-title":"The iron exporter ferroportin\/Slc40a1 is essential for iron homeostasis","volume":"1","author":"Donovan","year":"2005","journal-title":"Cell Metabolism"},{"issue":"11","key":"10.1016\/bs.vh.2023.03.001_bb0140","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/ncb3053","article-title":"Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo","volume":"16","author":"Dowdle","year":"2014","journal-title":"Nature Cell Biology"},{"issue":"4","key":"10.1016\/bs.vh.2023.03.001_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060534","article-title":"Increased iron loading induces Bmp6 expression in the non-parenchymal cells of the liver independent of the BMP-signaling pathway","volume":"8","author":"Enns","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/bs.vh.2023.03.001_bb0150","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood-2003-03-0807","article-title":"Labile plasma iron in iron overload: Redox activity and susceptibility to chelation","volume":"102","author":"Esposito","year":"2003","journal-title":"Blood"},{"key":"10.1016\/bs.vh.2023.03.001_bb0155","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00109-009-0588-3","article-title":"Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form","volume":"88","author":"Fatih","year":"2010","journal-title":"Journal of Molecular Medicine"},{"issue":"4","key":"10.1016\/bs.vh.2023.03.001_bb0160","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1073\/pnas.95.4.1472","article-title":"The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding","volume":"95","author":"Feder","year":"1998","journal-title":"PNAS"},{"issue":"17","key":"10.1016\/bs.vh.2023.03.001_bb0165","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1182\/blood-2010-10-315507","article-title":"Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice","volume":"117","author":"Finberg","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/bs.vh.2023.03.001_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-197001000-00002","article-title":"Ferrokinetics in man","volume":"49","author":"Finch","year":"1970","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/bs.vh.2023.03.001_bb0175","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.gastro.2006.11.049","article-title":"Hepcidin activation during inflammation: Make it STAT","volume":"132","author":"Fleming","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/bs.vh.2023.03.001_bb0180","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ng0897-383","article-title":"Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene","volume":"16","author":"Fleming","year":"1997","journal-title":"Nature Genetics"},{"issue":"24","key":"10.1016\/bs.vh.2023.03.001_bb0185","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1182\/blood-2010-04-281360","article-title":"Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis","volume":"116","author":"Forejtnikova","year":"2010","journal-title":"Blood"},{"key":"10.1016\/bs.vh.2023.03.001_bb0190","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.exphem.2021.05.005","article-title":"Iron-loaded transferrin potentiates erythropoietin effects on erythroblast proliferation and survival: A novel role through transferrin receptors","volume":"99","author":"Fouquet","year":"2021","journal-title":"Experimental Hematology"},{"issue":"6","key":"10.1016\/bs.vh.2023.03.001_bb0195","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1172\/JCI85715","article-title":"Clinical iron deficiency disturbs normal human responses to hypoxia","volume":"126","author":"Frise","year":"2016","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.vh.2023.03.001_bb783","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3324\/haematol.2013.084624","article-title":"Manipulation of the hepcidin pathway for therapeutic purposes","volume":"98","author":"Fung","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/bs.vh.2023.03.001_bb0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.beha.2004.08.020","article-title":"Hepcidin--a regulator of intestinal iron absorption and iron recycling by macrophages","volume":"18","author":"Ganz","year":"2005","journal-title":"Best Practice & Research. Clinical Haematology"},{"issue":"1","key":"10.1016\/bs.vh.2023.03.001_bb0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12185-017-2366-2","article-title":"Iron and infection","volume":"107","author":"Ganz","year":"2018","journal-title":"International Journal of Hematology"},{"issue":"11","key":"10.1016\/bs.vh.2023.03.001_bb0210","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1182\/blood-2006-09-048868","article-title":"Ineffective erythropoiesis in \u03b2-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin","volume":"109","author":"Gardenghi","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/bs.vh.2023.03.001_bb0215","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1172\/JCI41717","article-title":"Hepcidin as a therapeutic tool to limit iron overload and improve anemia in \u03b2-thalassemic mice","volume":"120","author":"Gardenghi","year":"2010","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.vh.2023.03.001_bb0220","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2013-08-521625","article-title":"Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus","volume":"123","author":"Gardenghi","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/bs.vh.2023.03.001_bb0225","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3324\/haematol.2014.117325","article-title":"Reversal of hemochromatosis by apotransferrin in non-transfused and transfused Hbbth3\/+ (heterozygous B1\/B2 globin gene deletion) mice","volume":"100","author":"Gelderman","year":"2015","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/bs.vh.2023.03.001_bb0230","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1309\/6BQ5K8LHVYAKUAF4","article-title":"The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the \"early\" prepolycythemic phase of polycythemia vera and essential thrombocythemia","volume":"130","author":"Gianelli","year":"2008","journal-title":"American Journal of Clinical Pathology"},{"issue":"24","key":"10.1016\/bs.vh.2023.03.001_bb777","doi-asserted-by":"crossref","first-page":"25866","DOI":"10.1074\/jbc.M401467200","article-title":"HFE and transferrin directly compete for transferrin receptor in solution and at the cell surface","volume":"279","author":"Giannetti","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"issue":"10","key":"10.1016\/bs.vh.2023.03.001_bb0235","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/s41375-018-0207-9","article-title":"Dysregulated iron metabolism in polycythemia vera: Etiology and consequences","volume":"32","author":"Ginzburg","year":"2018","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/bs.vh.2023.03.001_bb0240","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.exphem.2008.10.004","article-title":"Exogenous iron increases hemoglobin in beta-thalassemic mice","volume":"37","author":"Ginzburg","year":"2009","journal-title":"Experimental Hematology"},{"key":"10.1016\/bs.vh.2023.03.001_bb0245","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bcp.2011.03.030","article-title":"Tumor necrosis factor alpha-mediated inhibition of erythropoiesis involves GATA-1\/GATA-2 balance impairment and PU.1 over-expression","volume":"82","author":"Grigorakaki","year":"2011","journal-title":"Biochemical Pharmacology"},{"issue":"9","key":"10.1016\/bs.vh.2023.03.001_bb0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-123-9-199511010-00003","article-title":"Polycythemia vera: The natural history of 1213 patients followed for 20 years","volume":"123","author":"Gruppo Italiano Studio Policitemia","year":"1995","journal-title":"Annals of Internal Medicine"},{"issue":"6641","key":"10.1016\/bs.vh.2023.03.001_bb0250","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/41343","article-title":"Cloning and characterization of a mammalian proton-coupled metal-ion transporter","volume":"388","author":"Gunshin","year":"1997","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.vh.2023.03.001_bb0255","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1172\/JCI66969","article-title":"Reducing TMPRSS6 ameliorates hemochromatosis and \u03b2-thalassemia in mice","volume":"123","author":"Guo","year":"2013","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/bs.vh.2023.03.001_bb0260","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.hoc.2014.04.009","article-title":"Iron-refractory iron deficiency anemia (IRIDA)","volume":"28","author":"Heeney","year":"2014","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"7","key":"10.1016\/bs.vh.2023.03.001_bb0265","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/bph.14143","article-title":"Sustained plasma hepcidin suppression and iron elevation by Anticalin-derived hepcidin antagonist in cynomolgus monkey","volume":"175","author":"Hohlbaum","year":"2018","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/bs.vh.2023.03.001_bb781","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.ijid.2010.11.003","article-title":"A comprehensive review of Vibrio vulnificus: An important cause of severe sepsis and skin and soft-tissue infection","volume":"15","author":"Horseman","year":"2011","journal-title":"International Journal of Infectious Diseases"},{"key":"10.1016\/bs.vh.2023.03.001_bb0270","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1182\/blood-2008-08-173641","article-title":"Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli","volume":"113","author":"Huang","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/bs.vh.2023.03.001_bb0275","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/31.2.6300220","article-title":"Receptor-mediated endocytosis of transferrin by developing erythroid cells from the fetal rat liver","volume":"31","author":"Iacopetta","year":"1983","journal-title":"The Journal of Histochemistry and Cytochemistry"},{"issue":"7037","key":"10.1016\/bs.vh.2023.03.001_bb0280","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/bs.vh.2023.03.001_bb780","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.1998.18.555","article-title":"Proinflammatory cytokines lowering erythropoietin production","volume":"18","author":"Jelkmann","year":"1998","journal-title":"Journal of Interferon & Cytokine Research"},{"issue":"1","key":"10.1016\/bs.vh.2023.03.001_bb0285","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cmet.2015.05.002","article-title":"SLC39A14 is required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis","volume":"22","author":"Jenkitkasemwong","year":"2015","journal-title":"Cell Metabolism"},{"issue":"13","key":"10.1016\/bs.vh.2023.03.001_bb0290","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood-2004-06-2477","article-title":"Diferric transferrin regulates transferrin receptor 2 protein stability","volume":"104","author":"Johnson","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/bs.vh.2023.03.001_bb0295","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/ph11040127","article-title":"Hepcidin therapeutics","volume":"11","author":"Katsarou","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"issue":"7","key":"10.1016\/bs.vh.2023.03.001_bb0300","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nature Genetics"},{"issue":"4","key":"10.1016\/bs.vh.2023.03.001_bb0305","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1182\/blood-2008-03-143354","article-title":"Iron regulates phosphorylation of Smad1\/5\/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver","volume":"112","author":"Kautz","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/bs.vh.2023.03.001_bb0310","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bcmd.2007.10.002","article-title":"Regulation of hepcidin: Insights from biochemical analyses on human serum samples","volume":"40","author":"Kemna","year":"2008","journal-title":"Blood Cells, Molecules & Diseases"},{"key":"10.1016\/bs.vh.2023.03.001_bb0315","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.20170396","article-title":"Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor","volume":"215","author":"Khalil","year":"2018","journal-title":"The Journal of Experimental Medicine"},{"issue":"6","key":"10.1016\/bs.vh.2023.03.001_bb0320","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ijid.2007.04.007","article-title":"Association of hemochromatosis with infectious diseases: Expanding spectrum","volume":"11","author":"Khan","year":"2007","journal-title":"International Journal of Infectious Diseases"},{"issue":"8","key":"10.1016\/bs.vh.2023.03.001_bb0325","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood-2013-08-521419","article-title":"A mouse model of anemia of inflammation: Complex pathogenesis with partial dependence on hepcidin","volume":"123","author":"Kim","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1016\/bs.vh.2023.03.001_bb0330","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1073\/pnas.80.8.2263","article-title":"Binding of apotransferrin to K562 cells: Explanation of the transferrin cycle","volume":"80","author":"Klausner","year":"1983","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/bs.vh.2023.03.001_bb0335","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1016\/S0021-9258(18)32481-5","article-title":"Receptor-mediated endocytosis of transferrin in K562 cells","volume":"258","author":"Klausner","year":"1983","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.vh.2023.03.001_bb0340","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00018-007-6561-9","article-title":"Interleukin-1beta inhibits the hypoxic inducibility of the erythropoietin enhancer by suppressing hepatocyte nuclear factor-4alpha","volume":"64","author":"Krajewski","year":"2007","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"17","key":"10.1016\/bs.vh.2023.03.001_bb0345","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.vh.2023.03.001_bb0350","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-5793(00)01920-7","article-title":"LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity","volume":"480","author":"Krause","year":"2000","journal-title":"FEBS Letters"},{"key":"10.1016\/bs.vh.2023.03.001_bb0355","series-title":"Efficacy of oral ferroportin inhibitor in a mouse model of polycythemia vera","author":"Kubovcakova","year":"2018"},{"issue":"1","key":"10.1016\/bs.vh.2023.03.001_bb0360","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0092-8674(00)81151-4","article-title":"Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor","volume":"93","author":"Lebr\u00f3n","year":"1998","journal-title":"Cell"},{"issue":"3","key":"10.1016\/bs.vh.2023.03.001_bb0365","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bcmd.2011.12.005","article-title":"Severe microcytic anemia but increased erythropoiesis in mice lacking Hfe or Tfr2 and Tmprss6","volume":"48","author":"Lee","year":"2012","journal-title":"Blood Cells, Molecules & Diseases"},{"issue":"3","key":"10.1016\/bs.vh.2023.03.001_bb0370","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1124\/mol.105.018481","article-title":"Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production","volume":"69","author":"Lee","year":"2006","journal-title":"Molecular Pharmacology"},{"issue":"24","key":"10.1016\/bs.vh.2023.03.001_bb0375","doi-asserted-by":"crossref","first-page":"17791","DOI":"10.1074\/jbc.M113.460253","article-title":"Each member of the poly-r(C)-binding protein 1 (PCBP) family exhibits iron chaperone activity toward ferritin","volume":"288","author":"Leidgens","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.vh.2023.03.001_bb0380","series-title":"Anti-ferroportin 1 monoclonal antibodies and uses thereof. US 8183346","author":"Leung","year":"2012"},{"issue":"11","key":"10.1016\/bs.vh.2023.03.001_bb0385","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1182\/blood-2016-09-742387","article-title":"Decreasing TfR1 expression reverses anemia and hepcidin suppression in \u03b2-thalassemic mice","volume":"129","author":"Li","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/bs.vh.2023.03.001_bb0390","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nm.2073","article-title":"Transferrin therapy ameliorates disease in beta-thalassemic mice","volume":"16","author":"Li","year":"2010","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/bs.vh.2023.03.001_bb0395","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1172\/JCI63924","article-title":"Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis","volume":"122","author":"Liu","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"issue":"13","key":"10.1016\/bs.vh.2023.03.001_bb0400","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.3390\/ijms22137229","article-title":"Ineffective erythropoiesis in \u03b2-thalassaemia: Key steps and therapeutic options by drugs","volume":"22","author":"Longo","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1016\/bs.vh.2023.03.001_bb0405","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1074\/jbc.M707125200","article-title":"Dimerization by a cytokine receptor is necessary for constitutive activation of JAK2V617F","volume":"283","author":"Lu","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.vh.2023.03.001_bb0410","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-394390-3.00001-X","article-title":"Transferrin-mediated cellular iron delivery","volume":"69","author":"Luck","year":"2012","journal-title":"Current Topics in Membranes"},{"issue":"4","key":"10.1016\/bs.vh.2023.03.001_bb0415","article-title":"Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis","author":"Mancias","year":"2015","journal-title":"eLife"},{"issue":"7498","key":"10.1016\/bs.vh.2023.03.001_bb0420","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias","year":"2014","journal-title":"Nature"},{"issue":"8","key":"10.1016\/bs.vh.2023.03.001_bb0425","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3324\/haematol.2009.020123","article-title":"Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE\/ARE sequence motif at position \u22127007 of the FPN1 promoter","volume":"95","author":"Marro","year":"2010","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/bs.vh.2023.03.001_bb0430","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3324\/haematol.2011.056119","article-title":"Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis","volume":"97","author":"Mastrogiannaki","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/bs.vh.2023.03.001_bb0435","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bcmd.2013.09.004","article-title":"Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells","volume":"52","author":"McCranor","year":"2014","journal-title":"Blood Cells, Molecules & Diseases"},{"issue":"5509","key":"10.1016\/bs.vh.2023.03.001_bb0440","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1126\/science.1057206","article-title":"An iron-regulated ferric reductase associated with the absorption of dietary iron","volume":"291","author":"McKie","year":"2001","journal-title":"Science"},{"issue":"10","key":"10.1016\/bs.vh.2023.03.001_bb0445","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ajh.20937","article-title":"Hemochromatosis and iron overload screening study research investigators. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study","volume":"82","author":"McLaren","year":"2007","journal-title":"American Journal of Hematology"},{"key":"10.1016\/bs.vh.2023.03.001_bb0450","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jcp.1041500109","article-title":"Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon","volume":"150","author":"Means","year":"1992","journal-title":"Journal of Cellular Physiology"},{"issue":"10","key":"10.1016\/bs.vh.2023.03.001_bb0455","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3324\/haematol.13342","article-title":"A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron","volume":"93","author":"Melis","year":"2008","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/bs.vh.2023.03.001_bb0460","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92002","article-title":"Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia","volume":"2","author":"Michels","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/bs.vh.2023.03.001_bb0465","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ng1152","article-title":"Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis","volume":"34","author":"Muckenthaler","year":"2003","journal-title":"Nature Genetics"},{"issue":"7","key":"10.1016\/bs.vh.2023.03.001_bb0470","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1182\/blood-2014-08-596254","article-title":"The second transferrin receptor regulates red blood cell production in mice","volume":"125","author":"Nai","year":"2015","journal-title":"Blood"},{"issue":"21","key":"10.1016\/bs.vh.2023.03.001_bb0475","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2012-01-401885","article-title":"Deletion of TMPRSS6 attenuates the phenotype in a mouse model of \u03b2-thalassemia","volume":"119","author":"Nai","year":"2012","journal-title":"Blood"},{"key":"10.1016\/bs.vh.2023.03.001_bb0480","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"issue":"7","key":"10.1016\/bs.vh.2023.03.001_bb0485","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI0215686","article-title":"The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation","volume":"110","author":"Nicolas","year":"2002","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/bs.vh.2023.03.001_bb0490","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/bcmd.2002.0573","article-title":"Hepcidin, a new iron regulatory peptide","volume":"29","author":"Nicolas","year":"2002","journal-title":"Blood Cells, Molecules & Diseases"},{"issue":"1","key":"10.1016\/bs.vh.2023.03.001_bb0495","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng1150","article-title":"Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis","volume":"34","author":"Nicolas","year":"2003","journal-title":"Nature Genetics"},{"issue":"12","key":"10.1016\/bs.vh.2023.03.001_bb0500","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood-2006-06-028787","article-title":"Suppression of hepcidin during anemia requires erythropoietic activity","volume":"108","author":"Pak","year":"2006","journal-title":"Blood"},{"key":"10.1016\/bs.vh.2023.03.001_bb0505","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fnut.2018.00103","article-title":"Inherited disorders of iron overload","volume":"5","author":"Pantopoulos","year":"2018","journal-title":"Frontiers in Nutrition"},{"key":"10.1016\/bs.vh.2023.03.001_bb0510","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver","volume":"276","author":"Park","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"issue":"17","key":"10.1016\/bs.vh.2023.03.001_bb0515","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.2018893099","article-title":"Lobe specificity of iron binding to transferrin modulates murine erythropoiesis and iron homeostasis","volume":"134","author":"Parrow","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/bs.vh.2023.03.001_bb0520","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1182\/blood-2012-12-471441","article-title":"Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with \u03b2-thalassemia major: A longitudinal study","volume":"122","author":"Pasricha","year":"2013","journal-title":"Blood"},{"issue":"10270","key":"10.1016\/bs.vh.2023.03.001_bb0525","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(20)32594-0","article-title":"Iron deficiency","volume":"397","author":"Pasricha","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/bs.vh.2023.03.001_bb0530","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjmed.2004.06.032","article-title":"Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia","volume":"117","author":"Passamonti","year":"2004","journal-title":"The American Journal of Medicine"},{"issue":"5","key":"10.1016\/bs.vh.2023.03.001_bb0535","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00043426-199909000-00014","article-title":"Ferrokinetics in the syndrome of familial hypoferremic microcytic anemia with iron malabsorption","volume":"21","author":"Pearson","year":"1999","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"7","key":"10.1016\/bs.vh.2023.03.001_bb0540","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1172\/JCI31370","article-title":"Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)","volume":"117","author":"Peyssonnaux","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"issue":"10","key":"10.1016\/bs.vh.2023.03.001_bb0545","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1182\/blood-2010-08-299859","article-title":"Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: Data from the HIGHCARE project","volume":"117","author":"Piperno","year":"2011","journal-title":"Blood"},{"key":"10.1016\/bs.vh.2023.03.001_bb0550","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fphar.2014.00086","article-title":"Hepcidin antagonists for potential treatments of disorders with hepcidin excess","volume":"5","author":"Poli","year":"2014","journal-title":"Frontiers in Pharmacology"},{"issue":"6","key":"10.1016\/bs.vh.2023.03.001_bb0555","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cmet.2012.03.018","article-title":"Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination","volume":"15","author":"Qiao","year":"2012","journal-title":"Cell Metabolism"},{"issue":"22","key":"10.1016\/bs.vh.2023.03.001_bb0560","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1182\/blood-2014-02-554634","article-title":"Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis","volume":"123","author":"Rampal","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1016\/bs.vh.2023.03.001_bb0565","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ajh.24417","article-title":"Hematopoietic deletion of transferrin receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemia","volume":"91","author":"Rishi","year":"2016","journal-title":"American Journal of Hematology"},{"issue":"13","key":"10.1016\/bs.vh.2023.03.001_bb778","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1182\/blood-2004-06-2481","article-title":"Regulation of transferrin receptor 2 protein levels by transferrin","volume":"104","author":"Robb","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/bs.vh.2023.03.001_bb0570","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI90519","article-title":"PCBP1 and NCOA4 regulate erythroid iron storage and heme biosynthesis","volume":"127","author":"Ryu","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"issue":"8","key":"10.1016\/bs.vh.2023.03.001_bb0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023109","article-title":"Hepcidin levels and their determinants in different types of myelodysplastic syndromes","volume":"6","author":"Santini","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.vh.2023.03.001_bb0580","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cmet.2007.11.016","article-title":"The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression","volume":"7","author":"Schmidt","year":"2008","journal-title":"Cell Metabolism"},{"issue":"2","key":"10.1016\/bs.vh.2023.03.001_bb0585","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cmet.2008.12.012","article-title":"Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency","volume":"9","author":"Shah","year":"2009","journal-title":"Cell Metabolism"},{"issue":"4","key":"10.1016\/bs.vh.2023.03.001_bb0590","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.4049\/jimmunol.1202716","article-title":"IL-22 regulates iron availability in vivo through the induction of hepcidin","volume":"191","author":"Smith","year":"2013","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.vh.2023.03.001_bb0595","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1182\/blood-2010-03-271791","article-title":"Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease","volume":"116","author":"Song","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/bs.vh.2023.03.001_bb0600","first-page":"895","article-title":"Myeloproliferative neoplasms","volume":"377","author":"Spivak","year":"2017","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/bs.vh.2023.03.001_bb0605","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1182\/blood-2017-03-772715","article-title":"Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron","volume":"130","author":"Stefanova","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/bs.vh.2023.03.001_bb0610","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00253-18","article-title":"Hepcidin protects against lethal Escherichia coli sepsis in mice inoculated with isolates from septic patients","volume":"86","author":"Stefanova","year":"2018","journal-title":"Infection and Immunity"},{"issue":"33","key":"10.1016\/bs.vh.2023.03.001_bb0615","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1200\/JCO.2015.61.6474","article-title":"Polycythemia vera: An appraisal of the biology and management 10 years after the discovery of JAK2 V617F","volume":"33","author":"Stein","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/bs.vh.2023.03.001_bb0620","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1038\/ncomms9545","article-title":"Outward- and inward-facing structures of a putative bacterial transition-metal transporter with homology to ferroportin","volume":"6","author":"Taniguchi","year":"2015","journal-title":"Nature Communications"},{"issue":"9","key":"10.1016\/bs.vh.2023.03.001_bb0625","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1629","article-title":"High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin","volume":"13","author":"Tanno","year":"2007","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/bs.vh.2023.03.001_bb0630","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ejh.12150","article-title":"Serum hepcidin and growth differentiation factor-15 (GDF-15) levels in polycythemia vera and essential thrombocythemia","volume":"91","author":"Tarkun","year":"2013","journal-title":"European Journal of Haematology"},{"key":"10.1016\/bs.vh.2023.03.001_bb0635","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1182\/blood-2011-03-345066","article-title":"Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats","volume":"118","author":"Theurl","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/bs.vh.2023.03.001_bb0640","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1078\/0344-0338-5710013","article-title":"Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients","volume":"197","author":"Thiele","year":"2001","journal-title":"Pathology, Research and Practice"},{"issue":"27","key":"10.1016\/bs.vh.2023.03.001_bb0645","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1073\/pnas.0603124103","article-title":"Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6","volume":"103","author":"Truksa","year":"2006","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/bs.vh.2023.03.001_bb0650","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13045-017-0427-x","article-title":"A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia","volume":"10","author":"Vadhan-Raj","year":"2017","journal-title":"Journal of Hematology & Oncology"},{"issue":"6","key":"10.1016\/bs.vh.2023.03.001_bb0655","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/clinids\/18.6.938","article-title":"Multiple liver abscesses due to Yersinia enterocolitica discloses primary hemochromatosis: Three cases reports and review","volume":"18","author":"Vadillo","year":"1994","journal-title":"Clinical Infectious Diseases"},{"issue":"20","key":"10.1016\/bs.vh.2023.03.001_bb776","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1073\/pnas.79.20.6186","article-title":"Receptor-mediated endocytosis of transferrin and the uptake of Fe in K562 cells: Identification of a nonlysosomal acidic compartment","volume":"79","author":"van Renswoude","year":"1982","journal-title":"PNAS"},{"key":"10.1016\/bs.vh.2023.03.001_bb0660","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1200\/JCO.2009.27.2377","article-title":"Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease","volume":"28","author":"van Rhee","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/bs.vh.2023.03.001_bb0665","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2141.1994.tb04864.x","article-title":"Inhibition of erythropoietin production in vitro by human interferon gamma","volume":"87","author":"Vannucchi","year":"1994","journal-title":"British Journal of Haematology"},{"key":"10.1016\/bs.vh.2023.03.001_bb0670","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00109-008-0313-7","article-title":"A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells","volume":"86","author":"Verga Falzacappa","year":"2008","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"key":"10.1016\/bs.vh.2023.03.001_bb0675","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.leukres.2017.01.032","article-title":"Markers of iron deficiency in patients with polycythemia vera receiving ruxolitinib or best available therapy","volume":"56","author":"Verstovsek","year":"2017","journal-title":"Leukemia Research"},{"issue":"6","key":"10.1016\/bs.vh.2023.03.001_bb0680","doi-asserted-by":"crossref","first-page":"667","DOI":"10.33549\/physiolres.930841","article-title":"Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis","volume":"55","author":"Vokurka","year":"2006","journal-title":"Physiological Research"},{"issue":"2","key":"10.1016\/bs.vh.2023.03.001_bb0685","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/5979","article-title":"Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse","volume":"21","author":"Vulpe","year":"1999","journal-title":"Nature Genetics"},{"issue":"44","key":"10.1016\/bs.vh.2023.03.001_bb0690","doi-asserted-by":"crossref","first-page":"18354","DOI":"10.1074\/jbc.M117.801795","article-title":"Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway","volume":"292","author":"Wahedi","year":"2017","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.vh.2023.03.001_bb0695","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cmet.2005.10.010","article-title":"A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression","volume":"2","author":"Wang","year":"2005","journal-title":"Cell Metabolism"},{"key":"10.1016\/bs.vh.2023.03.001_bb0700","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jcp.1041620116","article-title":"Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development","volume":"162","author":"Wang","year":"1995","journal-title":"Journal of Cellular Physiology"},{"issue":"6","key":"10.1016\/bs.vh.2023.03.001_bb0705","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood.2019002620","article-title":"Erythroferrone lowers hepcidin by sequestering BMP2\/6 heterodimer from binding to the BMP type I receptor ALK3","volume":"135","author":"Wang","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/bs.vh.2023.03.001_bb0710","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2141.2006.06258.x","article-title":"Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell-line HepG2 induced by thalassaemic sera","volume":"135","author":"Weizer-Stern","year":"2006","journal-title":"British Journal of Haematology"},{"key":"10.1016\/bs.vh.2023.03.001_bb0715","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3389\/fimmu.2017.00498","article-title":"Iron- and hepcidin-independent downregulation of the iron exporter ferroportin in macrophages during Salmonella infection","volume":"8","author":"Willemetz","year":"2017","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.vh.2023.03.001_bb779","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood-2006-06-027631","article-title":"Interleukin-6 induces hepcidin expression through STAT3","volume":"108","author":"Wrighting","year":"2006","journal-title":"Blood"},{"issue":"19","key":"10.1016\/bs.vh.2023.03.001_bb0720","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1182\/blood-2018-04-842997","article-title":"Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress","volume":"132","author":"Zhang","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/bs.vh.2023.03.001_bb0725","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2009.03.006","article-title":"A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression","volume":"9","author":"Zhang","year":"2009","journal-title":"Cell Metabolism"},{"key":"10.1016\/bs.vh.2023.03.001_bb0730","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.3748\/wjg.v17.i45.5032","article-title":"AG490: An inhibitor of hepcidin expression in vivo","volume":"17","author":"Zhang","year":"2011","journal-title":"World Journal of Gastroenterology"}],"container-title":["Vitamins and Hormones","Hormone Receptors: Structures and Functions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672923000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672923000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T21:32:06Z","timestamp":1694813526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672923000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780443134555"],"references-count":154,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2023.03.001","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}